NSCLC Patient >30 kg 10 mg/kg IV infusion over 60 min every 2 wk or 1,500 mg IV infusion over 60 min every 4 wk until disease progression, unacceptable toxicity or max: 12 mth,
patient ≤30 kg 10 mg/kg IV infusion over 60 min every 2 wk until wt increase to >30 kg.
ES-SCLC Patient >30 kg 1,500 mg IV infusion over 60 min in combination w/ chemotherapy every 3 wk for 4 cycles, followed by 1,500 mg every 4 wk as monotherapy until disease progression or unacceptable toxicity,
patient ≤30 kg 20 mg/kg IV infusion over 60 min in combination w/ chemotherapy every 3 wk for 4 cycles, followed by 20 mg/kg every 4 wk as monotherapy until wt increase to >30 kg.
BTC Patient >36 kg 1,500 mg IV infusion over 60 min in combination w/ chemotherapy every 3 wk for 8 cycles, followed by 1,500 mg every 4 wk as monotherapy until disease progression or unacceptable toxicity,
patient ≤36 kg 20 mg/kg IV infusion over 60 min in combination w/ chemotherapy every 3 wk for 8 cycles, followed by 20 mg/kg every 4 wk until wt increase to >36 kg.
Sign Out
 120 mg_2.4 mL25961993-e513-47d2-a771-afa20080fa59.GIF)
 500 mg_10 mLc573d05c-31de-422b-8dcd-afa20080fa67.GIF)
